Cancer cells can promote tumor cell‐induced platelet aggregation by expressing several platelet receptors such as GPIb and GPIIbIIIa, which promote interactions with platelet bridging proteins von-Willebrand’s factor, fibronectin and fibrinogen. This evidence concerns the gene FN1 and cancer.